Open Letter to the Chairman of FX Energy

The following letter was delivered to the Chairman of the Board of Directors of FX Energy on Thursday, June 27th, 2013. If you wish to join the mailing list of the Ad-Hoc Committee of FX Energy Shareholders and participate in our ongoing discussions as to how best to effectuate positive growth in shareholder value, please email fxen@littlebear.us

Read more

A New Day at FDA Leads The Way For Sarepta Therapeutics

Shareholders of Sarepta Therapeutics (Nsadaq: SRPT) could be excused for scratching their heads yesterday after the close when the common stock of the company traded down around 10% after what seemed to be positive news emanating from the FDA. In a highly anticipated press release, Sarepta announced the results of the company’s meeting with the FDA regarding the pathway to eventual approval for eteplirsen, a novel exon-skipping drug that shows tremendous promise in treating boys suffering from Duchenne’s Muscular Dystrophy (“DMD”).

Read more

Why the Bookies Are Wrong on Sarepta Therapeutics

The options market proves the old adage that there is no such thing as a free lunch. Investors who dabble in special situations expect that the marketplace knows the basic outlines of your thesis, and prices risk accordingly. That’s not to say you can’t make money betting on outcomes, just that the firms on the other side taking your wager always make sure that the table pays odds commiserate with the gamble.

Read more

FX Energy & the Kutno-2 : The Plot Thickens

(September 12, 2012) It’s been over 3 weeks since FX Energy (“FXEN”) last updated shareholders on the status of the Kutno-2 well, a wildcat operation hunting for what could be the largest natural gas find continental Europe has seen in years. As I described in great detail in my piece dated August 9th, the 35,000 acre mega-structure that is the Kutno prospect is a well-defined four-way dip closure that is Europe’s largest mega-structure currently identified that remains undrilled.

Read more

FX Energy : The El Gordo Lottery Ticket of Europe

(August 9th, 2012) Over the next month or so a small European gas company is poised to report results that could move this stock 300%. Yet it seems that few care, and fewer still have staked a position on the outcome. I’m one of the few who has. Read on to learn why you ought to consider doing so as well.

Read more

Harvesting Venezuelan Oil – The Bull Case for HNR

(April 4th, 2012) With crude sitting at $105 and change, oil & gas exploration companies with undervalued prospects have been all the rage. Therefore, its not often you find the stock of an oil company in the midst of an M&A transaction sitting squarely in the 50% off bin.  Yet that is exactly the case with Harvest Natural Resources (NYSE: HNR).

Read more

EGY : The $7 bet on the next Persian Gulf

(Feb 14th, 2012)  Every so often it’s important to review one’s own biggest trading mistakes. My second worst trading error of the past six months occurred in January, when I got long an expensive, controversial oil name, Cobalt Energy (NYSE: CIE). Cobalt started out life as a Goldman Sachs’ backed driller in the Gulf of Mexico, and built a tidy portfolio of value-added offshore drilling. In late December of last year, Cobalt’s stock took off, moving from $10 a share to around $15, on word that its’ holdings in offshore Angola, where it was completing the Cameia-1 appraisal well, had potentially struck a a monstrous find.

Read more

Qihoo 360 : See-No-Evil, Hear-No-Evil

Remember the 1980s oil & gas partnerships? Large E&P firms would pocket investor’s cash to shell out for leases, acrage, and the assorted equipment necessary to drill. The sky-high upfront leasing costs made sense only to investors with graphs prediction ever-rising energy prices. At the time, such pie-in-the-sky numbers looked like consensus. It was only when oil prices collapsed that in retrospect the O&G partnerships, as construed as an asset class, looked foolish. The losses were so steep, and the damage so widespread, that it took more than a decade before the Wall Street underwriting machine was able to lure the marks (er, clients) back into the business.

Read more

Page 3 of 41234

” Concentration is my motto – first honesty, then industry, then concentration. ” Andrew Carnegie